𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen replacement therapy for the breast cancer survivor: A reappraisal

✍ Scribed by Disaia, Philip J.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
103 KB
Volume
64
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Estrogen replacement therapy for ovarian
✍ Franco Guidozzi; Alexandros Daponte πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## BACKGROUND. Surgery for premenopausal and perimenopausal patients with epithelial ovarian carcinoma may often result in significant menopausal symptoms. Physicians may well be reluctant to prescribe, and patients loathe to take, postoperative estrogen replacement therapy because they fear that

The insulin-like growth factor-1 elevate
✍ S.E. Dunn; J.V. Torres; N. Nihei; J.C. Barrett πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su

Hormone replacement therapy and the risk
✍ Ingemar Persson; Erik Thurfjell; Reinhold BergstrΓΆm; Lars Holmberg πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 37 KB πŸ‘ 2 views

There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer